Nimodipine versus Flunarizine in Common Migraine: A Controlled Pilot Trial
Gennaro Bussone, S. Baldini, G D’Andrea, A.R. Cananzi, Fabio Frediani, L. Caresia, Francesco Milone, A. Boiardi
Abstract
Gennaro Bussone, S. Baldini, G D’Andrea, A.R. Cananzi, Fabio Frediani, L. Caresia, Francesco Milone, A. Boiardi
Abstract
SYNOPSIS The effects of Nimodipine and Flunarizine, both calcium‐antagonist drugs, in the prevention of common migraine were investigated in a double‐blind randomized parallel study. Five patients of the 30 included in the study dropped out because of adverse reactions. Two were treated with Nimodipine and three with Flunarizine. Our results suggest a similar efficacy for both drugs, although Nimodipine seems to have a shorter latency of effect. Nimodipine is a useful new agent for common migraine prevention.
OpenAlex reports 25 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
SYNOPSIS The effects of Nimodipine and Flunarizine, both calcium‐antagonist drugs, in the prevention of common migraine were investigated in a double‐blind randomized parallel study. Five patients of the 30 included in the study dropped out because of adverse reactions. Two were treated with Nimodipine and three with Flunarizine. Our results suggest a similar efficacy for both drugs, although Nimodipine seems to have a shorter latency of effect. Nimodipine is a useful new agent for common migraine prevention.
Key concepts: Flunarizine, Nimodipine, Medicine, Migraine, Anesthesia, Antagonist, Randomized controlled trial, Adverse effect